ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers.

MLA

Day, Evan K., et al. “ERK-Dependent Suicide Gene Therapy for Selective Targeting of RTK/RAS-Driven Cancers.” Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 29, no. 4, Apr. 2021, pp. 1585–601. EBSCOhost, https://doi.org/10.1016/j.ymthe.2020.12.019.

APA

Day, E. K., Campbell, A., Pandolf, A., Rogerson, T., Zhong, Q., Xiao, A., Purow, B., & Lazzara, M. J. (2021). ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers. Molecular Therapy : The Journal of the American Society of Gene Therapy, 29(4), 1585–1601. https://doi.org/10.1016/j.ymthe.2020.12.019

Chicago

Day, Evan K, Anne Campbell, Ashley Pandolf, Troy Rogerson, Qing Zhong, Aizhen Xiao, Benjamin Purow, and Matthew J Lazzara. 2021. “ERK-Dependent Suicide Gene Therapy for Selective Targeting of RTK/RAS-Driven Cancers.” Molecular Therapy : The Journal of the American Society of Gene Therapy 29 (4): 1585–1601. doi:10.1016/j.ymthe.2020.12.019.